Drugs / COMPOUND 2055269
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03503630 | Jul 2018 → Mar 2021 | — | Ali Shamseddine | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COMPOUND 2055269 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03503630 ↗ |